How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?
  • Question on Consultation

    Are the recommendations sound and a suitable basis for guidance to the NHS?
  • Question on Consultation

    Are there any additional equality or health inequalities issues we should consider?
  • Question on Consultation

    Has all of the relevant evidence been taken into account?

4 Committee members and NICE project team

This topic was considered by specialist committee members appointed for this topic and NICE's diagnostics advisory committee, which is a standing advisory committee of NICE.

Committee members are asked to declare any interests in the technologies to be evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

The minutes of each committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.

Chair

Thomas Clutton-Brock
Chair, diagnostics advisory committee

NICE project team

Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser, project manager and an associate director.

Sophie Harrison
Technical lead

Kimberley Carter
Technical adviser

Catherine Pank
Project manager

Rebecca Albrow
Associate director

ISBN: [to be added at publication]